Pathological Examination Market to Reach USD 773 Billion by 2030, Driven by Rising Chronic Disease Prevalence and Technological Advancements

Pathological Examination Market to Reach USD 773 Billion by 2030, Driven by Rising Chronic Disease Prevalence and Technological Advancements

According to Next Move Strategy Consulting, the global Pathological Examination Market is poised for significant growth, projected to expand to USD 773 billion by 2030, representing a compound annual growth rate (CAGR) of 13% by 2030. Pathological examinations, which are pivotal in diagnosing and treating diseases such as cancer, cardiovascular conditions, and diabetes, provide essential insights into the presence, nature, and extent of diseases, paving the way for personalized treatment plans.

Download Free Sample: https://www.nextmsc.com/pathological-examination-market/request-sample

Market Overview
Pathological examination involves the testing of tissues and bodily fluids such as blood, urine, and sputum to detect and analyze diseases. The market is growing due to the increasing incidence of chronic diseases globally and the rising demand for early disease detection, especially among the aging population. With a focus on precision medicine, advancements in technology like digital pathology, AI-based diagnostics, and 3D imaging are expected to accelerate market growth.

Market Dynamics and Trends
The demand for pathological testing is surging, fueled by the growing prevalence of chronic diseases, including cancer, cardiovascular disorders, and Type 2 diabetes, which account for a significant share of global mortality. As the geriatric population expands, particularly in regions like North America and Asia-Pacific, the need for early diagnosis is also increasing, further driving market demand.

Key players such as Abbott Pathology and Roche Ltd. are embracing new technologies, including collaborations to develop AI-based diagnostic tools. In February 2024, Roche Diagnostics partnered with PathAI to develop AI-driven digital pathology algorithms, enhancing diagnostic accuracy and expanding patient access to precision treatments. The ongoing integration of state-of-the-art techniques, including expansion microscopy and fluorescent in situ sequencing, is revolutionizing disease diagnosis and treatment at the cellular level.

However, challenges such as the shortage of skilled pathologists and the high cost of advanced diagnostics could potentially impede market growth. Despite these barriers, the increasing adoption of digital pathology and the development of 3D diagnostic technologies present lucrative opportunities for future growth.

Inquire Before Buying: https://www.nextmsc.com/pathological-examination-market/inquire-before-buying

Market Segmentation and Scope
The global pathological examination market is categorized based on type, service, application, end-users, and geography:

  • By Type: Conventional Pathology, Digital Pathology
  • By Service: Surgical Pathology, Anatomic Pathology, Cytopathology, Molecular Pathology, Clinical Pathology
  • By Application: Digestive Organs, Blood, Others
  • By End Users: Hospitals, Clinics, Ambulatory Surgical Centers
  • By Geography: North America, Europe, Asia-Pacific, Rest of World (RoW)

Geographical Analysis
North America currently leads the global market and is expected to maintain its dominance throughout the forecast period. This is due to robust healthcare infrastructure and increasing cases of chronic diseases such as cancer and cardiovascular conditions. The U.S., in particular, is set to experience a rise in cancer diagnoses, with projections suggesting over 2 million new cancer cases in 2024 alone.

Meanwhile, the Asia-Pacific region is also witnessing rapid growth, driven by the rising elderly population in countries like Japan, India, and China. With significant investments in healthcare diagnostics, such as India’s USD 4 billion influx in 2023, the demand for pathological examinations is expected to rise, addressing both age-related diseases and the expanding healthcare needs of the region.

Competitive Landscape
Key players in the global pathological examination market include Abbott Pathology, F. Hoffmann-La Roche Ltd., Sonic Healthcare, Quest Diagnostics Incorporated, NeoGenomics Laboratories, Merck KGaA, and Becton, Dickinson. Companies are adopting strategic collaborations and acquisitions to strengthen their market position. For example, Roche’s collaboration with Bristol Myers Squibb aims to advance personalized healthcare via digital pathology solutions. Sonic Healthcare’s acquisition of ProPath in 2021 demonstrates its commitment to integrating anatomical pathology with clinical laboratory testing.

Conclusion
The global pathological examination market is set for robust growth, driven by the rising prevalence of chronic diseases, aging populations, and advancements in diagnostic technologies. Although challenges such as workforce shortages and high costs persist, the increasing adoption of digital pathology and AI-based solutions promises to unlock new growth avenues. The market offers substantial opportunities for players to innovate and expand in both developed and emerging regions.

Also, Browse Related Reports:  

For more information, please contact:

Next Move Strategy Consulting

E-Mail: info@nextmsc.com

Direct: +1-217-650-7991

Website: www.nextmsc.com

Follow Us: LinkedIn | Twitter | Facebook | Instagram | YouTube

About Next Move Strategy Consulting:

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

Back to blog